Delivery Order 75N93021D00027-75N93024F00002

Award Date 9/30/24
Potential Completion Date 9/29/28
Potential Value $2.1M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc. The $102,610.29 order supports NIAID's Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases program, which conducts early-stage clinical trials of investigational products. The contract is part of a larger $545 million NIAID...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. The order, valued at $203,215, is for the contractor to provide clinical research management and conduct a Phase 1 clinical trial unit to evaluate therapeutics against infectious diseases. This order is part of a larger 5-year indefinite delivery/indefinite quantity contract...
This is a $214,395 delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc. for Phase 1 clinical trial support services to develop therapeutics against infectious diseases. The award is under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery/indefinite quantity (IDIQ) contract, which has a potential total value of $1,715,715.70. Icon Government And...
Icon Government and Public Health Solutions, Inc. was awarded a $2 million delivery order against the Comprehensive and Rapid Response to NIAID Research Programs master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The delivery order, with a period of performance from September 2021 through August 2022, is for comprehensive and rapid response services to support NIAID's research programs. Icon will provide these services on a...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. for a Phase I clinical trial unit to support development of therapeutics against infectious diseases. The contract has a potential value of $117,402.00 and is a Cost Plus Fixed Fee contract type. Icon Government And Public Health Solutions, Inc. is a global provider of outsourced...
This $12,925,678.00 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The contract supports the CARRRP PHASE II NEUROSYPHILIS STUDY and is a delivery order under NIAID's $545 million Comprehensive and Rapid Response to NIAID Research Programs indefinite delivery vehicle. The contract does not...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The $252,853.28 cost-plus-fixed-fee delivery order is for overall administrative and support activities, including procedures to identify, discuss, and develop scientific concepts, for the Scientific and Technical...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The contract, with a ceiling value of $174,002.53, was awarded to Icon Government And Public Health Solutions, Inc., a for-profit organization, to provide overall administrative and support activities for NIAID's Scientific and Technical Information Coordination and Tracking Group (STI CTG). This includes...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc., a for-profit organization. The $113,678.00 contract is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which enables streamlined ordering of clinical trial and...
This is a task order awarded under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery/indefinite quantity (IDIQ) contract, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). The task order, valued at $2,021,154, covers activities defined under two task areas of the IDIQ contract: Phase I healthy volunteer studies (Task Area C) and Phase I special population studies (Task Area D). The...

This is a $2,054,280 cost-plus-fixed-fee delivery order awarded to Icon Government And Public Health Solutions, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The order is part of NIAID's Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) indefinite delivery/indefinite quantity (IDIQ) contract, which supports a full range of NIAID research from basic studies to clinical trials. This particular delivery order, titled "NIAID CARRRP A2024-2 - VRC 020," has a period of performance through September 29, 2028. The contract does not utilize any set-aside designations. As a global provider of clinical research services, Icon will likely support protocol development, study execution, data management, and other key activities for this NIAID vaccine research and clinical trial.

Generated 10/2/24, 10:45 AM